These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 21277990

  • 41. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K, Krocova Z, Balonova L, Pejchal J, Stulik J, Macela A.
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [Abstract] [Full Text] [Related]

  • 42. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S, Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W.
    Vaccine; 2012 May 21; 30(24):3634-45. PubMed ID: 22484348
    [Abstract] [Full Text] [Related]

  • 43. Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice.
    Swain SD, Wright TW, Degel PM, Gigliotti F, Harmsen AG.
    Infect Immun; 2004 Oct 21; 72(10):5722-32. PubMed ID: 15385471
    [Abstract] [Full Text] [Related]

  • 44. Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis.
    Malik M, Bakshi CS, McCabe K, Catlett SV, Shah A, Singh R, Jackson PL, Gaggar A, Metzger DW, Melendez JA, Blalock JE, Sellati TJ.
    J Immunol; 2007 Jan 15; 178(2):1013-20. PubMed ID: 17202364
    [Abstract] [Full Text] [Related]

  • 45. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice.
    van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, Chen W.
    Infect Immun; 2007 Dec 15; 75(12):5597-608. PubMed ID: 17908807
    [Abstract] [Full Text] [Related]

  • 46. Earlier onset of neutrophil-mediated inflammation in the ultraviolet-exposed skin of mice deficient in myeloperoxidase and NADPH oxidase.
    Komatsu J, Koyama H, Maeda N, Aratani Y.
    Inflamm Res; 2006 May 15; 55(5):200-6. PubMed ID: 16830107
    [Abstract] [Full Text] [Related]

  • 47. Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis.
    Conlan JW, Zhao X, Harris G, Shen H, Bolanowski M, Rietz C, Sjostedt A, Chen W.
    Mol Immunol; 2008 May 15; 45(10):2962-9. PubMed ID: 18321578
    [Abstract] [Full Text] [Related]

  • 48. Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis.
    McCaffrey RL, Schwartz JT, Lindemann SR, Moreland JG, Buchan BW, Jones BD, Allen LA.
    J Leukoc Biol; 2010 Oct 15; 88(4):791-805. PubMed ID: 20610796
    [Abstract] [Full Text] [Related]

  • 49. Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus infection.
    Sun K, Metzger DW.
    J Immunol; 2014 Apr 01; 192(7):3301-7. PubMed ID: 24563256
    [Abstract] [Full Text] [Related]

  • 50. Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strain.
    Sharma J, Mares CA, Li Q, Morris EG, Teale JM.
    Microb Pathog; 2011 Apr 01; 51(1-2):39-47. PubMed ID: 21440052
    [Abstract] [Full Text] [Related]

  • 51. Neutrophil-mediated lung permeability and host defense proteins.
    Kantrow SP, Shen Z, Jagneaux T, Zhang P, Nelson S.
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct 01; 297(4):L738-45. PubMed ID: 19648288
    [Abstract] [Full Text] [Related]

  • 52. Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection.
    Pammit MA, Budhavarapu VN, Raulie EK, Klose KE, Teale JM, Arulanandam BP.
    Antimicrob Agents Chemother; 2004 Dec 01; 48(12):4513-9. PubMed ID: 15561819
    [Abstract] [Full Text] [Related]

  • 53. The impact of chemokine receptor CX3CR1 deficiency during respiratory infections with Mycobacterium tuberculosis or Francisella tularensis.
    Hall JD, Kurtz SL, Rigel NW, Gunn BM, Taft-Benz S, Morrison JP, Fong AM, Patel DD, Braunstein M, Kawula TH.
    Clin Exp Immunol; 2009 May 01; 156(2):278-84. PubMed ID: 19250281
    [Abstract] [Full Text] [Related]

  • 54. Transcriptional profiling of host responses in mouse lungs following aerosol infection with type A Francisella tularensis.
    Andersson H, Hartmanová B, KuoLee R, Rydén P, Conlan W, Chen W, Sjöstedt A.
    J Med Microbiol; 2006 Mar 01; 55(Pt 3):263-271. PubMed ID: 16476789
    [Abstract] [Full Text] [Related]

  • 55. Francisella tularensis induces aberrant activation of pulmonary dendritic cells.
    Bosio CM, Dow SW.
    J Immunol; 2005 Nov 15; 175(10):6792-801. PubMed ID: 16272336
    [Abstract] [Full Text] [Related]

  • 56. Infection of mice with Francisella as an immunological model.
    Conlan JW, Chen W, Bosio CM, Cowley SC, Elkins KL.
    Curr Protoc Immunol; 2011 Apr 15; Chapter 19():Unit 19.14. PubMed ID: 21462168
    [Abstract] [Full Text] [Related]

  • 57. Neutrophils: potential therapeutic targets in tularemia?
    Allen LA.
    Front Cell Infect Microbiol; 2013 Apr 15; 3():109. PubMed ID: 24409419
    [Abstract] [Full Text] [Related]

  • 58. Mechanisms of Francisella tularensis intracellular pathogenesis.
    Celli J, Zahrt TC.
    Cold Spring Harb Perspect Med; 2013 Apr 01; 3(4):a010314. PubMed ID: 23545572
    [Abstract] [Full Text] [Related]

  • 59. Production of Neutrophil Extracellular Traps Contributes to the Pathogenesis of Francisella tularemia.
    Pulavendran S, Prasanthi M, Ramachandran A, Grant R, Snider TA, Chow VTK, Malayer JR, Teluguakula N.
    Front Immunol; 2020 Apr 01; 11():679. PubMed ID: 32391009
    [Abstract] [Full Text] [Related]

  • 60. Francisella tularensis inhibits the intrinsic and extrinsic pathways to delay constitutive apoptosis and prolong human neutrophil lifespan.
    Schwartz JT, Barker JH, Kaufman J, Fayram DC, McCracken JM, Allen LA.
    J Immunol; 2012 Apr 01; 188(7):3351-63. PubMed ID: 22357630
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.